Martek DHA/ARA Pregnancy/Nursing Benefits Research Underway
This article was originally published in The Tan Sheet
Executive Summary
Martek Biosciences is developing DHA and ARA supplements for pregnant/lactating women and for cardiovascular health, CEO Henry Linsert announced during a recent analysts teleconference.
You may also be interested in...
DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches
Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.
DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches
Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.
DHA/ARA Term Infant Formula Negative Findings Cast Doubt On Launches
Negative research results relating to DHA/ARA supplementation of term infant formulas could delay the U.S. launch of formulas containing the fatty acids.